Rare non-Hodgkin lymphoma of childhood and adolescence: A consensus diagnostic and therapeutic approach to pediatric-type follicular lymphoma, marginal zone lymphoma, and nonanaplastic peripheral T-cell lymphoma

Varování

Publikace nespadá pod Lékařskou fakultu, ale pod Středoevropský technologický institut. Oficiální stránka publikace je na webu muni.cz.

Autoři	ATTARBASCHI A. ABLA O. PADILLA L.A. BEISHUIZEN A. BURKE G.A.A. BRUGIERES L. BRUNEAU J. BURKHARDT B. D AMORE E.S.G. KLAPPER W. KONTNY U. PILLON M. TAJ M. TURNER Suzanne Dawn UYTTEBROECK A. WOESSMANN W. MELLGREN K.
Rok publikování	2020
Druh	Článek v odborném periodiku
Časopis / Zdroj	PEDIATRIC BLOOD & CANCER
Fakulta / Pracoviště MU	Středoevropský technologický institut
Citace
www	https://onlinelibrary.wiley.com/doi/full/10.1002/pbc.28416
Doi	http://dx.doi.org/10.1002/pbc.28416
Klíčová slova	follicular lymphoma; marginal zone lymphoma; non-Hodgkin lymphoma; peripheral T-cell lymphoma; rare
Popis	Pediatric-type follicular (PTFL), marginal zone (MZL), and peripheral T-cell lymphoma (PTCL) account each for <2% of childhood non-Hodgkin lymphoma. We present clinical and histopathological features of PTFL, MZL, and few subtypes of PTCL and provide treatment recommendations. For localized PTFL and MZL, watchful waiting after complete resection is the therapy of choice. For PTCL, therapy is subtype-dependent and ranges from a block-like anaplastic large cell lymphoma (ALCL)-derived and, alternatively, leukemia-derived therapy in PTCL not otherwise specified and subcutaneous panniculitis-like T-cell lymphoma to a block-like mature B-NHL-derived or, preferentially, ALCL-derived treatment followed by hematopoietic stem cell transplantation in first remission in hepatosplenic and angioimmunoblastic T-cell lymphoma.